# FDA Inspection 1012244 - Regenerative Biologics, Inc. - March 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/18bf70d5-a56e-4da5-9517-191cfd74fb78
Source feed: FDA_Inspections

> FDA Inspection 1012244 for Regenerative Biologics, Inc. on March 29, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012244
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2017-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253781 - 2024-11-05](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/bea5c0d7-b2e0-4c92-b772-22fea7cf46d0)
- [FDA Inspection 1253781 - 2024-11-05](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/2a3fd411-804b-4efe-ae8e-996ad85aef6d)
- [FDA Inspection 1098286 - 2019-06-18](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/f1ad4853-0883-4c9f-8176-aa45f6c3e7cc)
- [FDA Inspection 914703 - 2015-02-19](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/6c9bfa5a-8945-47d0-a3ad-d4729b130610)
- [FDA Inspection 829781 - 2013-05-01](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/1d3c7004-ab14-4ff1-ba0a-227ab59e9737)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/a8637854-709f-4fb6-b3bb-28a009ab861d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d